🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

Recruitingn/aAges any - anyAllItalian Sarcoma Group
NCT06375941 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease. Exclusion Criteria: NA
💊

What it tests

  • Observational
📍

Where

19 sites
Istituto Clinico Humanitas Research Hospital IRCCS
Rozzano, Italy
Centro Riferimento Oncologico CRO
Aviano, Italy
AOU San Luigi Gonzaga
Orbassano, Italy
Istituto Tumori "Giovanni Paolo II" I.R.C.C.S.
Bari, Italy
Istituto Ortopedico Rizzoli IOR
Bologna, Italy
Policlinico "Sant'Orsola-Malpighi"
Bologna, Italy
A.O.U. Careggi
Florence, Italy
Ospedale Policlinico san Martino IRCCS
Genova, Italy

…and 11 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy